Vaccines

With many attendees traveling from out of town and possible skin-to-skin contact in the crowds, some may fear the festival will worsen the spread of monkeypox.

While cases have decreased dramatically, there are still thousands of cases being reported across the world, and hundreds of people are still dying from it every day in the United States.

The Centers for Disease Control and Prevention recommends the latest version of COVID-19 boosters to help protect against dominant subvariants of the virus.

A new study suggests that. yes, there are superdodgers. But explaining why they've been able to avoid the virus is a bit complicated.

The COVID-19 vaccine strategy may be shifting toward Americans getting yearly vaccinations, like many do with annual flu shots.

More than three months into the U.S. monkeypox outbreak, there's a welcome phrase coming from the lips of health officials who are steering the country's response: cautious optimism.

CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.

The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.

The Food and Drug Administration is planning to authorize a new generation of COVID-19 boosters this week that for the first time will target the omicron variant.

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.